Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
57,417,494
-
Total 13F shares
-
28,549,056
-
Share change
-
+28,549,056
-
Total reported value
-
$940,508,000
-
Price per share
-
$33.90
-
Number of holders
-
44
-
Value change
-
+$940,508,000
-
Number of buys
-
44
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) as of Q3 2020
As of 30 Sep 2020,
Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,549,056 shares.
The largest 10 holders included
FMR LLC, Vivo Capital, LLC, Novo Holdings A/S, venBio Partners LLC, Newlight Partners LP, JANUS HENDERSON GROUP PLC, Aisling Capital Management LP, PERCEPTIVE ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, and BAKER BROS. ADVISORS LP.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.